Jing-lun Yen
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
3,4-dihydroxybenzalacetone from Phellinus linteus reduces glial activation, mitigates oxidative stress and inflammation, and preserves retinal function in ischemia-reperfusion-like injury.
Journal: Experimental eye research
Published: July 29, 2025
A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 05, 2024
Retinal protection by fungal product theissenolactone B in a sodium iodate-induced AMD model through targeting retinal pigment epithelial matrix metalloproteinase-9 and microglia activity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2022
Ergosta-7,9(11),22-trien-3β-ol Alleviates Intracerebral Hemorrhage-Induced Brain Injury and BV-2 Microglial Activation.
Journal: Molecules (Basel, Switzerland)
Published: April 01, 2021
HADC8 Inhibitor WK2-16 Therapeutically Targets Lipopolysaccharide-Induced Mouse Model of Neuroinflammation and Microglial Activation.
Journal: International journal of molecular sciences
Published: December 12, 2018
Theissenolactone C Exhibited Ocular Protection of Endotoxin-Induced Uveitis by Attenuating Ocular Inflammatory Responses and Glial Activation.
Journal: Frontiers in pharmacology
Published: December 07, 2017
The natural retinoprotectant chrysophanol attenuated photoreceptor cell apoptosis in an N-methyl-N-nitrosourea-induced mouse model of retinal degenaration.
Journal: Scientific reports
Published: July 01, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026